Literature DB >> 11768268

Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

I A Scotiniotis1, M R Lucey, D C Metz.   

Abstract

The importance of ammonia-producing Helicobacter pylori infection as a cause of subclinical encephalopathy in cirrhosis was investigated. In addition, a single psychometric test that can reliably detect subclinical hepatic encephalopathy was sought. Out-patients with cirrhosis and no overt encephalopathy underwent [14C]urea breath testing once and psychometric testing on two separate occasions, with an intervening course of clarithromycin/omeprazole if they had subclinical encephalopathy (two of four psychometric tests abnormal). Subclinical encephalopathy was present in 27 of 69 patients (39%), and Helicobacter pylori infection in 14 of 69 (20%). There was no association between the two conditions (P = 0.769). Subclinical encephalopathy resolved in 75% of treated Helicobacter pylori-positive patients and 37.5% of treated Helicobacter pylori-negative patients (P = 0.285). Number connection test-B had high reproducibility among untreated patients (R = 0.655) and high correlation (P < or = 0.01) with three surrogate gold standards. In stable cirrhotic patients, subclinical hepatic encephalopathy was found to: (1) have a high prevalence, (2) not be associated with Helicobacter pylori infection, and (3) be readily detected with the number connection test-B alone.

Entities:  

Mesh:

Year:  2001        PMID: 11768268     DOI: 10.1023/a:1012787731821

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Normative neuropsychological test performance: effects of age, education, gender and ethnicity.

Authors:  A J Saykin; R C Gur; R E Gur; D L Shtasel; K A Flannery; L H Mozley; B L Malamut; B Watson; P D Mozley
Journal:  Appl Neuropsychol       Date:  1995-05

2.  Neuropsychological aspects of portal-systemic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

3.  Hyperammonaemia and Helicobacter pylori.

Authors:  S Ito; H Miyaji; T Azuma; Y Li; Y Ito; T Kato; Y Kohli; M Kuriyama
Journal:  Lancet       Date:  1995-07-08       Impact factor: 79.321

4.  Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.

Authors:  A Zullo; V Rinaldi; P Meddi; C Hassan; S Winn; A F Attili
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

5.  Screening of subclinical hepatic encephalopathy.

Authors:  M Groeneweg; W Moerland; J C Quero; W C Hop; P F Krabbe; S W Schalm
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

6.  Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

Authors:  H Schomerus; W Hamster; H Blunck; U Reinhard; K Mayer; W Dölle
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

7.  Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy.

Authors:  F Salerno; P Moser; A Maggi; G Vitaliani; G Benetti
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

8.  Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No. 275.

Authors:  G P Gubbins; T E Moritz; L S Marsano; R Talwalkar; C J McClain; C L Mendenhall
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

9.  Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study.

Authors:  J J Chen; C S Changchien; D I Tai; S S Chiou; C M Lee; C H Kuo
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

10.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

View more
  4 in total

1.  Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.

Authors:  Shu-Jie Chen; Liang-Jing Wang; Qin Zhu; Jian-Ting Cai; Tao Chen; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

2.  Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China.

Authors:  Yu-Yuan Li; Yu-Qiang Nie; Wei-Hong Sha; Zheng Zeng; Fu-Ying Yang; Li Ping; Lin Jia
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 3.  Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.

Authors:  Shen-Shong Chang; Hsiao-Yun Hu
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

4.  Safe use of proton pump inhibitors in patients with cirrhosis.

Authors:  Rianne A Weersink; Margriet Bouma; David M Burger; Joost P H Drenth; S Froukje Harkes-Idzinga; Nicole G M Hunfeld; Herold J Metselaar; Margje H Monster-Simons; Sandra A W van Putten; Katja Taxis; Sander D Borgsteede
Journal:  Br J Clin Pharmacol       Date:  2018-06-07       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.